Related Experiment Video
Updated: Feb 22, 2026

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
Published on: June 12, 2017
DJ-1 activates autophagy in the repression of cardiac hypertrophy
Ruicong Xue1, Jingzhou Jiang1, Bin Dong1
1Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China; Key Laboratory on Assisted Circulation, Ministry of Health, Guangzhou, China.
Insights
DJ-1 protein deficiency worsens cardiac hypertrophy and autophagy impairment. Restoring DJ-1 levels may protect against heart failure by activating autophagy.
Area of Science:
- Cardiology
- Molecular Biology
- Cell Biology
Background:
- Cardiac hypertrophy is a risk factor for heart failure.
- Autophagy regulates cardiac hypertrophy.
- DJ-1 protein's role in autophagy and cardiac hypertrophy is unclear.
Purpose of the Study:
- Investigate DJ-1's role in cardiac hypertrophy.
- Determine if DJ-1 modulates autophagy during cardiac hypertrophy.
- Explore DJ-1's potential as a therapeutic target for heart failure.
Main Methods:
- Studied DJ-1 expression in pressure overload-induced cardiac hypertrophy models.
- Utilized DJ-1 knockout mice and in vitro cell models.
- Analyzed autophagy markers, mTORC1/mTORC2 phosphorylation, and cardiac hypertrophy phenotypes.
Main Results:
- DJ-1 expression decreased in cardiac hypertrophy, correlating with impaired autophagy.
- DJ-1 knockout mice showed exacerbated cardiac hypertrophy and pulmonary edema.
- DJ-1 deficiency impaired autophagy activation and enhanced mTORC1/mTORC2 phosphorylation.
- DJ-1 overexpression ameliorated phenylephrine-induced cardiac hypertrophy and promoted autophagy.
Conclusions:
- DJ-1 represses cardiac hypertrophy through autophagy activation.
- DJ-1 deficiency exacerbates cardiac hypertrophy by inhibiting autophagy.
- DJ-1 is a potential therapeutic target for preventing or treating cardiac hypertrophy and heart failure.
Abstract:
Cardiac hypertrophy is the risk factor of heart failure when the heart is confronted with pressure overload or neurohumoral stimuli. Autophagy, a conserved degradative pathway, is one of the important mechanisms involved in the regulation of cardiac hypertrophy. DJ-1 is a traditional anti-oxidative protein and emerging evidence suggested that DJ-1 might modulate autophagy. However, the regulation of autophagy by DJ-1 in the process of cardiac hypertrophy remains unknown. In our study, we firstly discovered that the expression of DJ-1declined in the process of pressure overload cardiac hypertrophy, and its alteration was parallel with the impairment of autophagy. Furthermore, we proved that DJ-1 knockout mice exhibited a more hypertrophied phenotype than wildtype mice in cardiac hypertrophy which indicated that DJ-1 is responsible for the repression of cardiac hypertrophy. Furthermore, DJ-1 knockout significantly exacerbated pulmonary edema due to cardiac hypertrophy. In the process of cardiac hypertrophy, DJ-1 knockout significantly impaired autophagy activation and enhanced mTORC1 and mTORC2 phosphorylation were found. Similarly, our in vitro study proved that DJ-1 overexpression ameliorated phenylephrine (PE)-induced cardiac hypertrophy and promoted autophagy activation. Taken together, DJ-1 might repress both pressure overload and PE-induced cardiac hypertrophy via the activation of autophagy.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy

